RadNet (NasdaqGM:RDNT) in our automated value investing analysis, with the cash flow history and price comparison below.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold RadNet to reach your target.
Based on historical returns, we believe that RadNet can grow its free cash at a rate of about 31%. That's positive!
| Advantages | Disadvantages | Neutral |
|---|---|---|
|
|
|
| RDNT Price (RadNet stock price per share) |
$76.97 | |
| PE Ratio versus Sector | 62% higher than other Healthcare stocks | |
| PE Ratio versus Industry | 78% lower than other Diagnostics & Research stocks | |
| Cash Yield | 1.27% | |
| Free Cash Flow Jitter | 42% |
In the six months to 2026-11-13, no insider bought shares, and 3 insiders sold in 4 trades, about $3.0 million.
The six months before that had 0 buys and 11 sales.
Open-market buys and sells reported by RadNet's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-18 | SWARTZ DAVID L | Sell | 2,699 | $53.89 |
| 2026-06-16 | Wesdorp Cornelis (Pres & CEO, Digital Health) | Sell | 4,750 | $58.11 |
| 2026-06-15 | Forthuber Stephen M (Pres & CEO-Eastern Operations) | Sell | 24,214 | $57.79 |
| 2026-06-15 | Forthuber Stephen M (Pres & CEO-Eastern Operations) | Sell | 19,853 | $58.61 |
| 2026-03-19 | Sorensen Alma Gregory (Chief Strategy Officer) | Sell | 5,346 | $62.82 |
| 2026-03-19 | Sorensen Alma Gregory (Chief Strategy Officer) | Sell | 100 | $63.59 |
| 2026-03-19 | Sorensen Alma Gregory (Chief Strategy Officer) | Sell | 9,554 | $61.84 |
| 2026-03-18 | Sorensen Alma Gregory (Chief Strategy Officer) | Sell | 800 | $62.72 |
| 2026-03-18 | Sorensen Alma Gregory (Chief Strategy Officer) | Sell | 14,200 | $62.12 |
| 2025-12-05 | Forthuber Stephen M (Pres & COO-Eastern Operations) | Sell | 31,790 | $77.99 |
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 8,878,163 shares shorted. With 65,833,753 shares available for purchase and an average trading volume over the past 10 trading days of 1,008,820, it would take at least 8.8 days for all of the short holders to cover their shorts.
Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth
Each year names the SEC filer that reported it, so a change of filer shows up here.
| Fiscal year | SEC filer (CIK) | Free cash flow (USD millions) |
|---|---|---|
| 2009 | 790526 | 70.5 |
| 2010 | 790526 | 15.2 |
| 2011 | 790526 | 54.7 |
| 2012 | 790526 | 72.3 |
| 2013 | 790526 | 63.3 |
| 2014 | 790526 | 8.7 |
| 2015 | 790526 | 44.4 |
| 2016 | 790526 | 68.2 |
| 2017 | 790526 | 113.9 |
| 2018 | 790526 | 75.2 |
| 2019 | 790526 | 59.2 |
| 2020 | 790526 | 206.8 |
| 2021 | 790526 | 123.9 |
| 2022 | 790526 | 126.3 |
| 2023 | 790526 | 215.4 |
| 2024 | 790526 | 233.0 |
| 2025 | 790526 | 298.8 |
Download the yearly data as CSV.
Every one of the 17 fiscal years we have for RadNet under its current filer shows positive free cash flow.
At $76.97, RadNet trades below our safe value estimate of $77.71 and our fair value estimate of $119.56.
RadNet's average free cash flow rose sharply, from $46.8 million in its earliest three years to $249.1 million in its latest three.
Free cash flow is volatile from year to year, with a variability measure of 42%.
We do not have a dividend yield for RadNet.
Before you act on any of this, read what a margin of safety means and check the company's own filings.
Its trailing P/E ratio is 62% above the average for stocks in the Healthcare sector.
Its trailing P/E ratio is 78% below the average for stocks in the Diagnostics & Research industry.
A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.
Every fiscal year on this page is reported by one SEC filer, CIK 790526.
Each figure on this page comes from that filer.
Advertisement supports free stock analysis content.
Does RadNet have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to RDNT: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles
What are The Dow, S&P 500, and NASDAQ Indexes?
What is Liquidity in Stocks and Financial Instruments?
Why Do Companies Perform Stock Buybacks?